Introduction
Plasmacytoid dendritic cells (pDCs) are major type I interferon (IFN-I) producing cells (IPCs) in response to viral infections 1 due to selective expression of Toll-like receptors (TLR) 7 and 9 and constitutive expression of interferon response factor 7 (IRF-7). They migrate to inflamed lymph nodes (LN) through high endothelium venules during viral and bacterial infections 2, 3 and provide an important link between innate and adaptive immunity, enhancing natural killer (NK) cell activity and adaptive immune responses.
Blood pDC counts and pDC-dependent IFN-I production levels in vitro decrease in patients infected with human immunodeficiency virus (HIV) [4] [5] [6] [7] [8] . These decreases are generally correlated with a fall in CD4+ T-cell counts, inversely correlated with plasma viral load, and are associated with opportunistic infections 5, 6, [9] [10] [11] [12] . The reduction in circulating pDC numbers during HIV infection may be related to their direct infection 6, 9, 13 , or to redistribution to lymphoid organs, as suggested in the chronic asymptomatic stage of HIV infection 14 .
In nonhuman primate models of HIV infection, the IFN-I innate response is an early immunological event [15] [16] [17] . Rhesus macaque pDCs are activated and produce IFN-I in vitro in response to pathogenic simian immunodeficiency virus (SIV) 18, 19 like their human counterparts in response to HIV 20, 21 . Strong depletion of pDC from blood and lymphoid tissues are reported in the end stage of SIV infection 19, 22 , and attributed to infection and to higher levels of apoptosis. However, although the HIV/SIV interplay with the host immune response during primary infection is a key event, probably determining the later progression to disease, little is known about the role of pDC in immune regulation at this early stage.
We predicted that HIV/SIV infection may have an impact on the dynamics of circulating and LN DC, and on their functions in the first few days of infection 23, 24 and that it may induce immune suppression through IFN-I production and indoleamine-2,3-dioxygenase (IDO)
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For personal use only. on . by guest www.bloodjournal.org From activity. IDO is the rate limiting enzyme responsible for the extrahepathic catabolism of the essential aminoacid tryptophane (Trp) and is triggered by type I and II interferons [25] [26] [27] .
Abnormal production/activation of IDO is associated with inefficient immunological responses to infections, including HIV/SIV and cancer 26, [28] [29] [30] and is induced by HIV in human pDC in vitro 20, 21 . There is growing evidence to suggest that pDC are involved in the induction of tolerance, through IDO-dependent mechanisms 31 . This suggests that pDC may target immune suppression during the acute phase of HIV/SIV infection.
We focused on the dynamics of pDC during primary infection by carrying out fine timeresolution sampling of blood, and a longitudinal analysis of peripheral lymph nodes, using absolute quantification, to investigate the possible homing of these cells into lymphoid tissues. In parallel, the kinetics of virus replication, IFN-I and II responses, and IDO activity were analyzed, to improve our understanding of the contributions of virus and IFNs to IDO activation in vivo. We also analyzed pDC and IDO dynamics as a function of the dynamics of FoxP3+CD25+CD8+ T cells and SIV-specific T-cell proliferative responses during primary infection (Karlsson et al., 2007b) . Experiments were performed in 18 cynomolgus macaques, and the role of virus infection was assessed by using two different infectious doses or by using post-exposure antiretroviral treatment.
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Material and methods

Animals
Young adult cynomolgus macaques (Macaca fascicularis) weighing 3 to 5 kg were imported from Mauritius and kept according to European guidelines for animal care ("Journal Officiel des Communautés Européennes", L358, December 18, 1986 ). Blood sampling, biopsies and treatment were carried out in macaques anesthetized by intramuscular injection of 10 mg/kg ketamine (Rhone-Mérieux, Lyon, France). Six macaques received 5,000 animal infectious dose 50% (AID 50 ) of SIVmac251 intravenously (iv; 5,000 AID 50 group), six received 50 AID 50 iv (50 AID 50 group), and six were infected iv with 50 AID 50 and treated from 4 hours to 28 days post-exposure (pi). This ART group was given a combination of 4.5 mg/kg AZT, 2.5 mg/kg 3TC and 20 mg/kg Indinavir twice daily, via the oral route, as previously described 32 . Virus stock was kindly provided by Dr A.M. Aubertin (Université Louis Pasteur, Strasbourg, France).
Phenotypic characterization and intracellular staining
Blood samples were collected into CPT tubes for the isolation of PBMCs, according to manufacturer's recommendations. Cells were incubated with FcR blocking reagent (Miltenyi Biotech) for 10 min at room temperature and labeled with monoclonal antibodies (Supplemental Table 1 ) specific for CD123, HLA-DR, and either CD4, or CD7 , or CD11b, or CD36, or CD40, or CD45RA, or CD80, or CD86, or CD184 (CXCR4), or CD185 (CCR5), or CD206, or CD1c (BDCA-1), or with isotypic control antibodies for 20 min at +4°C. Cells were then washed in PBS, and fixed in Cell Fix (BD Biosciences). PDC were gated on CD123 bright , HLA-DR + cells as described 24 .
For IFN-α intracellular labeling, PBMC were stimulated by incubation for 6 hours with 6
For personal use only. on . by guest www.bloodjournal.org From HSV-I at a multiplicity of infection of 0.5 or with 20 µg/ml total protein from aldrithiol-2 (AT-2)-inactivated SIVmac239 (SIV-AT2). Brefeldin A (Sigma Aldrich) was added (10 µg/ml) for the last 4 hours. Mock stimulation with AT-2-treated SupT1 microvesicles was used as a negative control. AT-2-inactivated SIVmac239 (ARP1018.1) and its negative control (ARP1018.2) were obtained from Dr. Jeff Lifson (NCI, Frederick, MD, USA), through the EU Program EVA Centralized Facility for AIDS Reagents (NIBSC, Potters Bar, UK). Intracellular staining was performed using anti-human IFN-α2a monoclonal antibody (kindly provided by Dr Jacques Banchereau, Baylor Institute for Immunology Research, Dallas, Texas, USA), as previously described 24 .
Plasma viral load, T-cell counts, and T-cell proliferation assay
Plasma viral load was determined by real-time PCR, and T-cell counts, including FoxP3+ T cells, were determined by flow cytometry as described previously 33 . T-cell proliferation assay in response to inactivated SIV was performed as reported 33 .
pDC quantification
Absolute numbers of lineage -HLA-DR + CD123 + CD1c -pDC were quantified in whole blood using TruCount tubes 24 .
Lymph node biopsies were weighed, dilacerated and passed through cell strainers (BD Biosciences Small blocks of lymph node tissue were snap-frozen in liquid nitrogen and stored at -80°C.
Ten µm sections were cut with a CM1500 cryotome (Shandon, Thermo Scientific, Courtaboeuf, France), dried for 30 mn, fixed for 10 mn in acetone, and used directly for labeling or stored at -20°C. Sections were washed in PBS and non specific sites were blocked by incubation in 0.3% BSA, 0.5% SAB, 2% NGS (normal goat serum) in PBS for 30 mn.
Endogenous biotins were blocked using an avidin biotin blocking kit (Vector Laboratories, Peterborough, UK). Sections were then incubated for 90 minutes with the following primary antibodies: 25 µg/ml anti-CD123 (clone 7G3, BD Biosciences), 0.2 µg/ml anti-CD20 (clone L26, Dako), 12 µg/ml anti-CD3 (rabbit polyclonal, Dako) and appropriate isotypic controls.
Sections were washed twice in 0.5% Tween 20 (Sigma Aldrich) in PBS. They were then incubated for 1 hour with secondary antibodies (0.5 µg/ml biotinylated goat-antimouse IgG1or IgG2a (Caltag) and either 5 µg/ml Alexa 546-conjugated goat-antimouse IgG1 or IgG2a (Molecular Probes) or 10 µg/ml TRITC-conjugated goat-antirabbit IgG (Caltag).
Sections were washed twice and biotinylated antibodies were detected by incubation for 15 mn incubation with 1 µg/ml streptavidin-Alexa-fluor-488 (Invitrogen). The sections were washed again, stained for nuclei for 10 mn in 1/20,000 4', 6-diamidino-2-phenylindole (DAPI, Sigma Aldrich), then incubated with 0.5 M glycine in PBS for 30 mn. Slides were mounted with the Fluoromount Kit (Dako). All sections were analyzed under an Axiovert 100M microscope (Zeiss, Le Pecq, France) equipped with an Orca-ER CCD camera 1344x1024 pixels (Hamamatsu photonics, Hamamatsu City, Japan), and images were colorized using Image J 1.38 software.
Determination of IDO activity
Kyn and Trp concentrations were measured in macaque plasma from EDTA-treated blood, using high-performance liquid chromatography (HPLC) with coulometric detection 34 . The group). These macaques with high background levels were excluded from subsequent analysis.
In vitro stimulation of pDC
Aldrithiol-2 (AT-2)-inactivated SIVmac239 (2 μg/ml total protein, equivalent to 560 ng/ml p27) or herpes simplex virus (HSV) 1 (6 x 10 5 PFU) was added to 1 ml of whole blood for 18 hours at 37°C. Plasma samples were collected and stored at -80°C until use for IFN-I titration. Negative controls of stimulation included mock-stimulation and stimulation with AT-2-treated SupT1 microvesicles.
Statistical analysis
The nonparametric Spearman's rank correlation test was used to investigate the relationships between parameters. The nonparametric Mann-Whitney test was used to compare different 9
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From groups of macaques, and the nonparametric Wilcoxon rank test was used to compare data from the same macaques at different time points before and after SIV infection. In some cases, we calculated the AUC for analysis of the amplitude of variation of a given parameter during primary infection. Statistical analyses were carried out with Statview software (SAS Institute, Inc., Cary, N.C.). In two-tailed tests, p values of 0.05 or lower were considered significant.
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Results
Changes in pDC numbers during primary SIV infection
Twelve macaques were exposed iv to 50 AID 50 (n=6) or to 5,000 AID 50 (n=6) of SIVmac251.
Profound changes in pDC numbers were observed in the blood after infection ( Figure 1A ).
The earliest change was a significant transient increase during the first week of infection (mean 2.28 fold increase; range 1.23 -4.22). This increase was rapidly followed by an acute decrease between days 9 and 14 (mean 16% of baseline; range 2 to 31% of baseline).
Plasmacytoid DC counts decreased earlier in the 5,000 AID 50 group than in the 50 AID 50 group, but the nadir was not significantly different, mirroring kinetics and amplitudes of the viral load peak ( Figure 1B ). PDC numbers then gradually increased to subnormal values at 3 months p.i., staying below baseline from plasma viral load setpoint (month 3) to month 9 p.i.
(data not shown, p < 0.0001).
The decrease in pDC counts paralleled the decrease in CD4 + T-cell counts ( Figure 1C ) and pDC counts were correlated with CD4 + T-lymphocyte counts at setpoint (p=0.05) and 9 months post-infection (p=0.03). PDC counts were not correlated with plasma viral loads, although dynamics of pDC in the blood were strongly related to the kinetics of viremia, higher infectious doses resulting in earlier peak of viremia and earlier changes in pDC blood counts than lower doses.
As blood pDC counts were not correlated with viral load and the acute decline of pDC levels in the blood was partly corrected during chronic infection in cynomolgus macaques, we 6 to 156 x 10 6 pDC/g (increase from baseline levels by a factor of 2 to 49 on day 38).
Nine months after infection, the number of pDC in lymph nodes was lower than during primary infection, but remained greater than preinfection levels (p=0.002). The percentages of pDC in total lymph node cells paralleled that of absolute numbers (data not shown).
The ratios of pDC to other cell populations counted by flow cytometry (CD20+ B cells, To further highlight the impact of virus replication on pDC dynamics, a third group of six macaques was exposed to 50 AID 50 of SIVmac251 and then treated with ART (AZT, 3TC
and indinavir) four hours to 28 days after infection. As shown in figure 3A , macaques in this group showed a delay of the viral load peak of 2 days on average (mean 17 days ± 3 days vs 15 ± 3 days for the 50 AID 50 untreated group, Mann Whitney test p=0.005). Viral load peaks were also lower in the treated group (median peak viral load 3.06 x 10 4 copy/ml vs. 1.39 x 10 6 copy/ml, p=0.025). In treated macaques, the transient decrease in CD4+ T-cell counts was delayed and attenuated (mean nadir 45% ± 9% of baseline CD4+ T-cell count vs 21% ± 7%, p=0.004) ( Figure 3B ). Similarly, the transient decrease in blood pDC absolute counts
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Indeed, in ART treated macaques pDC decreased to a mean nadir of 41% ± 16% of baseline counts whereas in untreated macaques the nadir of pDC was lower 17% ± 8% of baseline counts (p=0.02). The absolute numbers of pDC increased in peripheral lymph nodes following infection ( Figure 3D ), and this increase did not differ significantly from those in untreated macaques.
Acute peaks of plasma IFN-I correlate with IDO activity and IL-18 production, all being closely synchronized to the increase of viremia during the acute phase As previously reported for rhesus macaques 15, 17 , IFN-I levels peaked during the increase in viremia ( Figure 4A ), two to three days earlier in the 5,000 AID 50 group than in the 50 AID 50 group (between day 7 and 9, mean 8.8 ± 0.4 days, vs between days 9 and 11, mean 10.2 ± We also determined plasma concentrations of IL-18, because this pro-inflammatory cytokine is induced by IFN-I 37 and induces IFN-γ in NK cells 17, 38 . IL-18 is also a potent chemoattractant for human pDC 39 . A peak of IL-18 was evidenced in the plasma ( Figure 4B ).
The peak of IL-18 occurred 2 to 3 days after the peak of IFN-I.
A peak of plasma IFN-γ concentrations was observed in a limited number of macaques, one of the five animals of the 50 AID 50 group and three of four animals of the 5,000 AID 50 group studied ( Figure 4C ). When detectable, the IFN-γ peak was temporally associated with the
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As IFN-I and HIV are both inducers of the immune suppression-associated enzyme indoleamine-2,3-dioxygenase (IDO) in human pDC in vitro 21 , we analyzed functional IDO activity in vivo. IDO catalyzes extrahepatic tryptophan (Trp) catabolism in the kynurenine (Kyn) pathway and measurement of their respective concentrations in serum is used as a marker of IDO activity 40 . A peak was observed for Kyn (mean peak value 2.24 ± 0.56 μM compared to 0.53 ± 0.08 μM at baseline), coinciding with the increase in plasma viremia ( Figure 4D ). This transient acute Kyn peak was associated with a transient decrease in Trp concentration, which returned to normal values by 3 months post-infection ( Figure 4E ). As a consequence, the Kyn/Trp ratio increased as viral load increased towards its peak ( Figure   4F ), with significantly more rapid kinetics (p=0.03) in the 5,000 AID 50 group (peaking from day 9 to 11, mean 9.3 ± 0.8) than in the 50 AID 50 group (day 9 to 14, mean 11.2 ± 1.6). IDO activity decreased after the peak, but remained higher at set point than at baseline (p=0.002), by a factor of 1.23 to 2.29 (mean 1.83 ± 0.27). Thus, the dynamics of IFN-I, IDO and IL-18
were highly coordinated with the exponential increase in viral load during primary infection.
IFN-I and Kyn were synchronous with the exponential increase of viremia whereas IL-18
and IFN-γ increased later. Virus and IFN-I appeared to be the earliest inducers of IDO detected in the acute phase.
Innate immunity was strongly reduced in ART treated macaques, which showed reduced and delayed peaks of plasma IFN-I ( Figure 4G ). No increase in IL-18 concentration was observed ( Figure 4H ), and only one of four macaques analyzed in this group showed a transient, atypical increase in plasma IFN-γ concentration ( Figure 4I ). In these animals, IDO activity did not increase significantly during treatment, a slight increase being observed after treatment interruption ( Figure 4J ), suggesting that post-exposure treatment may attenuate
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For Therefore, acute IDO activity was strongly correlated with both IFN-I concentration and viremia, but not with IFN-gamma concentration, during primary infection.
As viral load peaked after Kyn concentration, whereas IFN-I concentration peaked earlier, these data suggest that IFN-I plays a key role in the early phase of acute IDO activation although a direct virus-induced IDO activation in this study in vivo is not excluded as reported in human pDC in vitro 21 .
Primary infection is associated with a transient acute reduction in IFN-I production by pDC in response to viral stimulation in vitro
Human pDC rapidly become refractory to secondary stimulation in vitro 41 , a phenomenon proposed to account for decreased in vitro production of IFN-I in HIV infected patients 42 . As IFN-I became undetectable soon after its concentration peaked in the plasma, despite the persistence of high viral loads in our study, we compared the capacity of pDC to respond to SIV and HSV-1 stimulation before and after this peak, to evaluate a possible refractory phase in vivo.
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In vitro, cynomolgus macaque pDC underwent rapid IFN-α synthesis in response to SIV stimulation ( Figure 5A ), as previously shown in response to HSV stimulation 24 . These cells were also characterized extensively by flow cytometry (Supplemental Figure 3) . Cynomolgus pDC share common characteristics with human and rhesus macaque pDC in response to HIV and SIV, respectively 43, 44 . In PBMC stimulation assays, most IFN positive cells clustered in the pDC gate and no other IFN-positive cell population was evidenced outside the pDC gate ( Figure 5A ). In addition, in whole blood stimulation assays, IFN-I production was strongly correlated with the amount of pDC in the blood sample ( Figure 5B ). Then, we tested blood samples after infection, to follow IFN-I production by pDC in response to in vitro stimulation.
Before infection, IFN-I production per pDC was close to one IU per pDC ( Figure 5C ), as reported for human pDC 1, 45 . On day 35 after infection, IFN-I production per pDC in response to HSV was significantly lower, by a factor of about two on average (Wilcoxon, p=0.002), and then it gradually increased, with pre-infection values recovered nine months after infection. IFN-I production per pDC in response to SIV was also strongly decreased (by a log on average) on day 35 after infection ( Figure 5D ). Then it was partly restored but by contrast to what was observed for HSV stimulation, responses to SIV remained low 9 months post-infection (p=0.05 compared to uninfected macaques).
These data demonstrate that in addition to profound dynamic changes, pDC rapidly become refractory to IFN-I production in response to de novo stimulation during acute infection. This decrease probably results from intense stimulation in vivo during the acute phase of SIV infection, accounting for the rapid, but transient, acute plasma IFN-I peak.
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IDO activity correlates positively with virus load and FoxP3 + CD25 + CD8+ T cells, and negatively with both antigen-specific T-cell proliferation and CD4+ T-cell activation
We then analyzed IFN-I and IDO dynamics in relation with the adaptive immune response.
We recently described the dynamics of adaptive immunity in these macaques 33 14 . These data contrast with other reports both in a group of HIV-1 infected patients with low CD4+ T-cell counts 52 , and in SIV infected macaques with simian AIDS 19, 22 . One possible interpretation which would reconcile these divergent results is that pDC increase in lymphoïd tissues in early stage of infection and are depleted in later stages as a consequence of infection 19 and/or increased cell death 22 .
Several factors may account directly or indirectly to early relocation of pDC: the high levels of viral replication observed in lymphoid organs 53,54 , the acute IL-18 burst we observed, as this cytokine was recently shown to act as a chemoattractant for human pDC in vitro 39 In ART treated macaques, although transient decrease of pDC in the blood was lower than in untreated macaques, increase of pDC in peripheral lymph nodes was similar. Possible interpretations could be that pDC relocation to other lymphoid organs such as spleen or mucosal tissues could be affected by ART or that cell death and/or infection of pDC are reduced in these macaques.
Our data strongly suggest that pDC contribute to the rapid and acute increase in plasma IFN-I concentration in vivo, even though other cells, such as macrophages, might also contribute to the peak in plasma IFN-I concentration in vivo.
First, we observed that the relocation of pDC to lymph nodes and the decrease in blood pDC counts were concomitant with the increase in viral load and plasma IFN-I concentration, suggesting production at the site of virus replication in the lymphoid organs. Second, we
showed that macaque pDC underwent activation, maturation and rapid IFN-I production in response to SIV stimulation in vitro, as previously described in human pDC 18,19 ,20 . Third, pDC became unresponsive to secondary stimulation once the acute IFN-I response was over, suggesting that they were desensitized for IFN-I production in vivo as observed previously for human pDC in vitro after primary stimulation with TLR-9 ligand 41 and consistent with the reduced ability of pDC to produce IFN-I in response to in vitro stimulation in HIV infected patients 42 . Fourth, we did not evidence IFN-I-positive cell clusters outside the pDC gate in our in vitro stimulation studies.
For the first time, our study monitored the acute transient burst of IDO activity in parallel with acute changes in pDC dynamics and IFN-I concentration in the early phase of viremia.
The kinetic of IDO activity in cynomolgus macaques in our study and the positive correlation
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For Although IFN-γ is a major inducer of IDO in vitro 25, 59 , and correlates positively with IDO activity during chronic HIV infection 40, 60 We also investigated the relationship between innate and adaptive immune responses. We recently reported the dynamics of FoxP3+ CD4+ and CD8+ T cells during infection in the same animal cohort 33 . In the present work, we analyzed the relationship between these and innate immunity. IFN-I and IDO were shown to provide important signals for the induction of CD4+ Tregs in vitro 62, 63 . We found no correlation of FoxP3+ CD4+ Tregs, which declined in the blood and were not increased in peripheral lymph nodes 33 , with IFN-I or IDO activity (data not shown), although we can not exclude a different picture from other lymphoid organs which were not available in this study.
In contrast, we observed a transient expansion of CD25 Post-exposure antiretroviral treatment has major repercussions on both viremia and innate immunity, weakening the IFN-I response, abolishing the IL-18 peak, limiting pDC dynamic changes during acute infection, and suppressing acute increase in IDO activity. This may favor the early development of more efficient adaptive immune responses, and better longterm viremia control as shown in this and our previous study 32 . Low levels of IFN-I production were also observed in macaques infected with attenuated ∆nef SIVmac 15 , which also display lower viral load and develop an efficient adaptive immune response 72, 73 .
Therefore, low viremia during primary infection is associated with lower levels of IFN-I production, weaker immune suppression, better adaptive immunity and improved control of viremia in the long term. This suggests that acute production of IFN-I early during primary HIV/SIV infections may limit the capacity of the host to fight infection as recently shown in the mouse/MCMV infection model 74 .
In conclusion, our in vivo longitudinal study strongly suggests that greater viral expansion during primary infection leads to a stronger interferon response and transient induction of immunosuppressive agents, dampening antigen-specific CD4+ T-cell responses. IFN-I plays a major role in antiviral immunity 75 , but our results show a strong correlation between IFN-I concentration, virus replication levels and markers of immune suppression during primary infection, suggesting opposite effects on cellular immunity. As plasmacytoid DC home to lymph nodes during the acute phase of infection and are most likely involved in the acute production of IFN-I, they appear as key elements in this duality. For personal use only. on October 28, 2017. by guest www.bloodjournal.org From
